Characteristics of patients receiving immune checkpoint inhibitors (ICI) in ASCO’s CancerLinQ

2019
Rubinstein WS, Chen L, Komatsoulis GA, Stepanski E, Jun M, Zhi J, Lau D, Roberts J, Miller RS, Walker MS, Fukushima R, Hyde B, Khozin S
Read more